Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCCR
Schwab Core Bond ETF
SCCR
|
+$623M |
| 2 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$608M |
| 3 |
Applovin
APP
|
+$402M |
| 4 |
Amazon
AMZN
|
+$340M |
| 5 |
Lockheed Martin
LMT
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$542M |
| 2 |
JPMorgan Chase
JPM
|
+$289M |
| 3 |
HES
Hess
HES
|
+$275M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$266M |
| 5 |
ANSS
Ansys
ANSS
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.34% |
| 2 | Financials | 11.49% |
| 3 | Consumer Discretionary | 9.42% |
| 4 | Healthcare | 9.25% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Dorian LPG
LPG
$1.95B
| $19.5M | ﹤0.01% |
654,925
+30,652
| +5% | +$920K |
|
1752
Vanguard Total International Bond ETF
BNDX
$83B
| $19.5M | ﹤0.01% |
394,550
-12,424
| -3% | -$613K |
|
|
GOLD
1753
Gold.com Inc
GOLD
$1.27B
| $19.5M | ﹤0.01% |
752,628
+217,050
| +41% | +$5.13M |
|
1754
IDEAYA Biosciences
IDYA
$3.53B
| $19.5M | ﹤0.01% |
715,538
-1,260
| -0.2% | -$30.5K |
|
1755
Invesco S&P International Developed Momentum ETF
IDMO
$4.29B
| $19.4M | ﹤0.01% |
+358,699
| New | +$18.8M |
|
1756
Agios Pharmaceuticals
AGIO
$2B
| $19.4M | ﹤0.01% |
482,186
+6,145
| +1% | +$231K |
|
1757
Omnicell
OMCL
$1.72B
| $19.3M | ﹤0.01% |
633,898
+17,875
| +3% | +$549K |
|
1758
IAMGOLD
IAG
$10.1B
| $19.2M | ﹤0.01% |
1,488,037
+177,379
| +14% | +$1.55M |
|
1759
Braze
BRZE
$3.36B
| $19.2M | ﹤0.01% |
675,750
+87,850
| +15% | +$2.49M |
|
1760
Hertz
HTZ
$838M
| $19.1M | ﹤0.01% |
2,815,523
-70,990
| -2% | -$456K |
|
1761
BlueLinx
BXC
$705M
| $19.1M | ﹤0.01% |
261,890
+15,028
| +6% | +$1.18M |
|
1762
Green Plains
GPRE
$1.09B
| $19.1M | ﹤0.01% |
2,177,304
+111,774
| +5% | +$979K |
|
1763
CONMED
CNMD
$1.49B
| $19.1M | ﹤0.01% |
406,415
+8,274
| +2% | +$429K |
|
1764
GeneDx Holdings
WGS
$2.36B
| $19M | ﹤0.01% |
176,503
+8,900
| +5% | +$970K |
|
1765
DXP Enterprises
DXPE
$3B
| $19M | ﹤0.01% |
159,608
+13,324
| +9% | +$1.49M |
|
1766
BigBear.ai
BBAI
$1.6B
| $19M | ﹤0.01% |
2,914,332
+2,136,146
| +275% | +$13.7M |
|
1767
HCI Group
HCI
$2.32B
| $19M | ﹤0.01% |
98,813
+15,285
| +18% | +$2.42M |
|
1768
Amdocs
DOX
$6.23B
| $18.9M | ﹤0.01% |
230,115
+4,522
| +2% | +$392K |
|
1769
Deluxe
DLX
$1.11B
| $18.8M | ﹤0.01% |
973,517
+160,158
| +20% | +$2.92M |
|
1770
Arcutis Biotherapeutics
ARQT
$3.25B
| $18.8M | ﹤0.01% |
999,434
+34,368
| +4% | +$542K |
|
1771
WisdomTree
WT
$3.44B
| $18.8M | ﹤0.01% |
1,352,335
+62,001
| +5% | +$828K |
|
1772
Iris Energy
IREN
$16B
| $18.7M | ﹤0.01% |
399,265
-419,317
| -51% | -$10.2M |
|
1773
Gentherm
THRM
$1.32B
| $18.7M | ﹤0.01% |
549,975
+15,521
| +3% | +$525K |
|
1774
Edgewell Personal Care
EPC
$1.31B
| $18.7M | ﹤0.01% |
917,172
+45,753
| +5% | +$1.07M |
|
|
TIC
1775
TIC Solutions Inc
TIC
$2.19B
| $18.6M | ﹤0.01% |
1,398,507
+550,194
| +65% | +$6.27M |
|
Similar funds
Charles Schwab's Q3 2025 Portfolio in Review
As of Q3 2025, Charles Schwab held 3,560 positions worth $626B, up 8.3% from $578B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.8%. Charles Schwab opened 66 new positions and exited 105, leaving the 3,560-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Consumer Discretionary.
- Charles Schwab's largest Q3 2025 buy was BitMine Immersion Technologies: 1,712,780 shares worth $88.9M.
- Charles Schwab added most to Schwab Core Bond ETF in Q3 2025, an estimated $623M increase.
- Charles Schwab's biggest Q3 2025 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $542M.
- Charles Schwab fully exited Hess in Q3 2025, selling an estimated $275M.
- Charles Schwab's ten largest holdings make up 25% of its $626B portfolio in Q3 2025.
- Charles Schwab opened 66 new positions and closed 105 in Q3 2025.
- Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $626B.
Based on Charles Schwab's 13F filing for Q3 2025, filed 10 Nov 2025.